BioCentury
ARTICLE | Finance

Cratering market spoils Imara’s NASDAQ debut

March 13, 2020 12:05 AM UTC

Imara managed to make its public debut Thursday after raising $75.2 million in an IPO; however, the hemoglobinopathy company’s shares were immediately swept up in Thursday’s market turmoil.

Imara Inc. (NASDAQ:IMRA) slipped $1 to $15 Thursday and lost an additional $1.45 (10%) to $13.55 after hours, as both the broader market and key biotech indexes fell 9-11%...

BCIQ Company Profiles

Imara Inc.

Passage Bio Inc.